Our Scientific Advisory Council
The Bryn Pharma Scientific Advisory Council consists of a carefully selected team of experts. Their diverse perspectives help us to have a comprehensive understanding of the anaphylaxis treatment landscape. Our advisors are not only leaders in their respective clinical areas but also have extensive experience in clinical development, patient engagement training, and other relevant fields. This enables Bryn Pharma to achieve its patient-centric approach. We believe that this group includes some of the most influential physicians in their respective areas of expertise, and we are confident that their knowledge and insights will play a significant role in our decision-making process.